Related Experiment Video
Updated: May 28, 2025
07:39
Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
Published on: November 17, 2021
3.4K
Pediatric subcutaneous nasal glial heterotopia
Moajeb Turki Alzahrani1, Balgess Abdullah Ajlan2, Alaa Samkari3
1Department of Neuroscience, Section of Neurosurgery, King Abdulaziz Medical City National Guard Health Affairs, Jeddah, Saudi Arabia.
Surgical Neurology International
|February 10, 2025
Summary
Nasal glial heterotopias (NGHs) are congenital lesions. Surgical excision is recommended between 6-12 months for optimal outcomes in pediatric patients.
Area of Science:
- Pediatric Surgery
- Dermatology
- Plastic Surgery
Background:
- Nasal glial heterotopias (NGHs) are congenital benign lesions.
- Complete surgical excision is the standard treatment for NGHs.
- The optimal timing for NGH resection remains unclear.
Observation:
- A case of a 4-day-old female newborn with a midline subcutaneous extranasal glial heterotopia on the nasal bridge is presented.
- The patient underwent complete surgical excision at 6 months of age.
- Follow-up MRI at 3 years showed no recurrence.
Findings:
- A review of 19 published cases of purely subcutaneous extranasal glial heterotopia in pediatric patients was conducted.
- Surgery for NGH is safe and effective when performed between 6 to 12 months of age.
- Long-term follow-up until school age is recommended.
Implications:
- Early surgical intervention for NGH within the 6-12 month window appears safe and effective.
- This timing may contribute to favorable patient outcomes and minimize recurrence risk.
- Establishing optimal surgical timing aids in managing pediatric NGH cases.
